SciSparc Awarded European Patent

(24/7 MARKET NEWS) – SciSparc Ltd. (NASDAQ:SPRC) REPORTED, THIS MORNING, today that The European Patent Office awarded it a new patent, European Application No. 16786064.2, titled “Combinations of Cannabinoids and N-Acylethanolamines (the “Patent”)”, which aligns with the Company’s objective to increase the safety of cannabinoids treatments while maintaining their therapeutic effects.

SciSparc is trading at $9.80, up $3.99 (+103.74%), on 5.88M premarket shares traded.

Its 52-week range is $3.9357 to 13.64. It’s trading post reverse split and is trading above its recent resistance points, but it’s a foreign based listing and it has a bunch of volume from the revrse split announcement, so scalp or short swing should be the mindset and this tends to trade better in the premarket.

 24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.